Increased expression of ECM molecules by CAFs elevates tumor stiffness, which activates oncogenic intracellular signaling pathways, such as β-catenin, Akt, PI3K, and focal adhesion kinase (FAK) pathways, and silences tumor suppressor genes, such as phosphatase and tensin homolog [122]. Here, PTK2 is linked to neoplasm.